Genetic basis of atherosclerosis: part II: clinical implications.
about
The actin associated protein palladin in smooth muscle and in the development of diseases of the cardiovasculature and in cancer.Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein EA novel model of cholesterol efflux from lipid-loaded cellsCan novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal CanadiansABCG1 rs57137919G>a polymorphism is functionally associated with varying gene expression and apoptosis of macrophages.Lactase persistence and lipid pathway selection in the MaasaiGenetic determinants of atherosclerosis, obesity, and energy balance in consomic mice.A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI.Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.Genetic variations in the osteopontin promoters T-443C and G-156GG increase carotid intima-media thicknessReverse cholesterol transport and cholesterol efflux in atherosclerosis.VNN1 gene expression levels and the G-137T polymorphism are associated with HDL-C levels in Mexican prepubertal childrenExcess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk?Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.Can iron chelators influence the progression of atherosclerosis?Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivoNutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American WomenClinical pharmacology and pharmacogenetics in a genomics era: the DMET platform.Diagnosis and management of familial dyslipoproteinemias.Plasma homocysteine and the genetics of cardiovascular disease.Cardioprotective role of vitamin D receptor in circulating endothelial cells of ApoE-deficient mice.EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis.FOXP3 genetic variant and risk of acute coronary syndrome in Chinese Han population.
P2860
Q30425751-86634391-09B2-4878-933C-EE817F2BA7D0Q30547579-356A2EE4-BBE9-485D-9180-AB19D029FAA3Q33344456-456D9D83-3056-4B31-AF91-4BF4A1FD3AF2Q33577644-87943B4B-C8CC-4F8F-9DD4-AED08CDDA890Q33735780-942F2CAB-9414-4282-8B24-C1375DE68B49Q33741245-32536A86-72BA-4DE8-BF85-9BB438B246DAQ33817168-84B707B0-7095-46D8-9AE6-45FFC42A61B1Q34427355-B8F75C8A-56F4-43B4-83D1-259DE97DE509Q34559840-EA120BE9-B14E-4790-8C71-ACB3153C12E3Q34559909-4DD81936-5F92-492B-88FE-598143E4F5A0Q35666587-F7C68135-2AB0-4A7E-B559-A74B4BBDEDCEQ36044433-A1EE4876-12D7-4841-904D-9E2851FE3028Q36300834-E2390F06-3805-4576-A4D5-6DBB109F89FEQ36417161-C6233303-6342-4738-A888-975D0144C6D1Q37019901-4E058142-7908-4779-85D4-6CDA70B97A72Q37072194-334B79BF-5F5A-4F29-ABC0-2F12FA8C5227Q37084727-143EF8AC-D158-448C-837B-07157D9662BBQ37138039-A1792990-2412-4F7D-9991-49D75499AE4EQ37280276-8AEA45D5-EE40-42B4-93B2-C0D0FD0D8E1FQ37401949-8F61816A-0754-49FA-B1FB-AF11F0B92F23Q37576928-184BAB79-9C59-4E44-98CF-FCC75D0CE556Q37657540-3D1A882B-0F0D-4EB8-A20F-145E210F5CA8Q38105993-0430C5C1-50ED-4305-9F26-EE5CEFC2D02BQ40347863-5D4F28BE-3C41-45CA-B042-C016C1E130C6Q40779618-4F362115-3DDA-432E-8D27-3A0F1C1A1CD6Q42755373-5E3482DC-1F27-4718-B16C-30D272B158ABQ43482569-A564734F-9A49-4EF4-ABC6-90D21FFA07CF
P2860
Genetic basis of atherosclerosis: part II: clinical implications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genetic basis of atherosclerosis: part II: clinical implications.
@ast
Genetic basis of atherosclerosis: part II: clinical implications.
@en
type
label
Genetic basis of atherosclerosis: part II: clinical implications.
@ast
Genetic basis of atherosclerosis: part II: clinical implications.
@en
prefLabel
Genetic basis of atherosclerosis: part II: clinical implications.
@ast
Genetic basis of atherosclerosis: part II: clinical implications.
@en
P1433
P1476
Genetic basis of atherosclerosis: part II: clinical implications.
@en
P2093
Alan M Fogelman
P304
P356
10.1161/01.CIR.0000143098.98869.F8
P407
P577
2004-10-01T00:00:00Z